A Bayesian Dose-Individualization Method for Warfarin.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 1, p. 59, doi. 10.1007/s40262-012-0017-6
- By:
- Publication type:
- Article
Works matching IS 03125963 AND DT 2013 AND VI 52 AND IP 1
Results: 6
1
2
Optimal Sampling Times for a Drug and its Metabolite using SIMCYP® Simulations as Prior Information.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 1, p. 43, doi. 10.1007/s40262-012-0022-9
- By:
- Publication type:
- Article
3
Fluticasone Furoate, a Novel Inhaled Corticosteroid, Demonstrates Prolonged Lung Absorption Kinetics in Man Compared with Inhaled Fluticasone Propionate.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 1, p. 37, doi. 10.1007/s40262-012-0021-x
- By:
- Publication type:
- Article
4
Pharmacokinetics of Non-Intravenous Formulations of Fentanyl.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 1, p. 23, doi. 10.1007/s40262-012-0016-7
- By:
- Publication type:
- Article
5
Benchmarking Therapeutic Drug Monitoring Software: A Review of Available Computer Tools.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 1, p. 9, doi. 10.1007/s40262-012-0020-y
- By:
- Publication type:
- Article
6
The Clinical Relevance of Plasma Protein Binding Changes.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 1, p. 1, doi. 10.1007/s40262-012-0018-5
- By:
- Publication type:
- Article